Skip to content

Graft Patency After FFR-guided Versus Angio-guided CABG (GRAFFITI) Trial

Graft Patency After FFR-guided Versus Angio-guided CABG: a Prospective, Multicenter, Multinational, Randomized (1:1) Controlled Trial

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01810224
Acronym
GRAFFITI
Enrollment
206
Registered
2013-03-13
Start date
2013-03-31
Completion date
Unknown
Last updated
2013-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Brief summary

This is prospective, randomized, multicenter, multinational, randomized (1:1) study. The aim of this study is to assess the importance of functional assessment of coronary artery disease prior to bypass surgery. In particular, an FFR-guided strategy will be compared to the traditional Angio-guided strategy in the guidance of surgical revascularization by aorto-coronary bypass grafting.

Interventions

The final intervention (surgical revascularization) will be the same for both arms.

Sponsors

Onze Lieve Vrouw Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Patients with stable angina, unstable angina or NSTEMI candidate to CABG * Significant LAD and/or LM lesion - proved by FFR or Angiography AND * At least one more, angiographycally intermediate lesion

Exclusion criteria

* Significant valvular disease with indication to surgical replacement * Severe left ventricular dysfunction (EF\<35%) * Acute STEMI * Atrial fibrillation, if Maze procedure is planned

Design outcomes

Primary

MeasureTime frame
Rate of occluded bypass grafts1 year

Secondary

MeasureTime frame
a) Lenght of hospital stay; b) Changes in surgical strategy: i.e. open-chest surgery vs. mini-thoracotomy; extensive surgery versus minimal invasive approaches.participants will be followed for the duration of hospital stay, an expected average of 3-4 weeks

Countries

Belgium, Czechia, Hungary

Contacts

Primary ContactEmanuele Barbato, MD, PhD
emanuele.barbato@olvz-aalst.be

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 6, 2026